COLOPLAST-B (CBHD.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:CBHD - DK0060448595 - Common Stock
78.12 EUR
-0.22 (-0.28%)
CBHD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 63 industry peers in the Health Care Equipment & Supplies industry. While CBHD has a great profitability rating, there are some minor concerns on its financial health. CBHD has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year CBHD was profitable.
CBHD had a positive operating cash flow in the past year.
CBHD had positive earnings in each of the past 5 years.
In the past 5 years CBHD always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 7.52%, CBHD belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
CBHD has a better Return On Equity (22.55%) than 92.06% of its industry peers.
CBHD has a better Return On Invested Capital (12.65%) than 90.48% of its industry peers.
CBHD had an Average Return On Invested Capital over the past 3 years of 13.59%. This is above the industry average of 9.33%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| ROIC | 12.65% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
1.3 Margins
CBHD has a better Profit Margin (13.04%) than 74.60% of its industry peers.
CBHD's Profit Margin has declined in the last couple of years.
CBHD's Operating Margin of 27.52% is amongst the best of the industry. CBHD outperforms 95.24% of its industry peers.
In the last couple of years the Operating Margin of CBHD has declined.
CBHD has a Gross Margin of 67.97%. This is in the better half of the industry: CBHD outperforms 74.60% of its industry peers.
CBHD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.52% | ||
| PM (TTM) | 13.04% | ||
| GM | 67.97% |
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CBHD is creating value.
CBHD has about the same amout of shares outstanding than it did 1 year ago.
CBHD has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CBHD has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.99 indicates that CBHD is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.99, CBHD is in the better half of the industry, outperforming 69.84% of the companies in the same industry.
The Debt to FCF ratio of CBHD is 4.34, which is a neutral value as it means it would take CBHD, 4.34 years of fcf income to pay off all of its debts.
CBHD's Debt to FCF ratio of 4.34 is fine compared to the rest of the industry. CBHD outperforms 61.90% of its industry peers.
A Debt/Equity ratio of 1.24 is on the high side and indicates that CBHD has dependencies on debt financing.
CBHD's Debt to Equity ratio of 1.24 is on the low side compared to the rest of the industry. CBHD is outperformed by 82.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 4.34 | ||
| Altman-Z | 3.99 |
ROIC/WACC2.19
WACC5.77%
2.3 Liquidity
CBHD has a Current Ratio of 1.61. This is a normal value and indicates that CBHD is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.61, CBHD is in line with its industry, outperforming 49.21% of the companies in the same industry.
CBHD has a Quick Ratio of 1.00. This is a normal value and indicates that CBHD is financially healthy and should not expect problems in meeting its short term obligations.
CBHD has a Quick ratio (1.00) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The earnings per share for CBHD have decreased strongly by -20.93% in the last year.
The Earnings Per Share has been decreasing by -2.02% on average over the past years.
The Revenue has been growing slightly by 3.12% in the past year.
CBHD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.49% yearly.
EPS 1Y (TTM)-20.93%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%-20.03%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.1%
3.2 Future
Based on estimates for the next years, CBHD will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.18% on average per year.
CBHD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.53% yearly.
EPS Next Y45.69%
EPS Next 2Y27.02%
EPS Next 3Y23.6%
EPS Next 5Y17.18%
Revenue Next Year5.7%
Revenue Next 2Y6.56%
Revenue Next 3Y7.67%
Revenue Next 5Y7.53%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CBHD is valuated quite expensively with a Price/Earnings ratio of 32.82.
The rest of the industry has a similar Price/Earnings ratio as CBHD.
When comparing the Price/Earnings ratio of CBHD to the average of the S&P500 Index (26.15), we can say CBHD is valued slightly more expensively.
CBHD is valuated rather expensively with a Price/Forward Earnings ratio of 22.55.
CBHD's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of CBHD to the average of the S&P500 Index (36.12), we can say CBHD is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.82 | ||
| Fwd PE | 22.55 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CBHD is valued a bit cheaper than 60.32% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CBHD is valued a bit cheaper than the industry average as 74.60% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.5 | ||
| EV/EBITDA | 15.82 |
4.3 Compensation for Growth
CBHD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CBHD has a very decent profitability rating, which may justify a higher PE ratio.
CBHD's earnings are expected to grow with 23.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.72
PEG (5Y)N/A
EPS Next 2Y27.02%
EPS Next 3Y23.6%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.99%, CBHD has a reasonable but not impressive dividend return.
CBHD's Dividend Yield is rather good when compared to the industry average which is at 2.22. CBHD pays more dividend than 98.41% of the companies in the same industry.
CBHD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.99% |
5.2 History
The dividend of CBHD has a limited annual growth rate of 5.30%.
Dividend Growth(5Y)5.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
136.36% of the earnings are spent on dividend by CBHD. This is not a sustainable payout ratio.
The dividend of CBHD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP136.36%
EPS Next 2Y27.02%
EPS Next 3Y23.6%
FRA:CBHD (11/27/2025, 7:00:00 PM)
78.12
-0.22 (-0.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners29.27%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap16.42B
Revenue(TTM)27.87B
Net Income(TTM)3.64B
Analysts68.46
Price Target93.67 (19.91%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.99% |
Yearly Dividend2.95
Dividend Growth(5Y)5.3%
DP136.36%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-25%
Min EPS beat(2)-26.06%
Max EPS beat(2)-23.94%
EPS beat(4)0
Avg EPS beat(4)-20.18%
Min EPS beat(4)-26.06%
Max EPS beat(4)-15.32%
EPS beat(8)0
Avg EPS beat(8)-12.22%
EPS beat(12)0
Avg EPS beat(12)-10.75%
EPS beat(16)1
Avg EPS beat(16)-9.6%
Revenue beat(2)0
Avg Revenue beat(2)-2.46%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)-2.12%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.37%
Revenue beat(12)1
Avg Revenue beat(12)-1.51%
Revenue beat(16)4
Avg Revenue beat(16)-0.95%
PT rev (1m)-0.89%
PT rev (3m)-3.26%
EPS NQ rev (1m)13.74%
EPS NQ rev (3m)11.87%
EPS NY rev (1m)-1.05%
EPS NY rev (3m)-3.53%
Revenue NQ rev (1m)6.06%
Revenue NQ rev (3m)4.69%
Revenue NY rev (1m)-0.39%
Revenue NY rev (3m)-1.37%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.82 | ||
| Fwd PE | 22.55 | ||
| P/S | 4.4 | ||
| P/FCF | 23.5 | ||
| P/OCF | 18.46 | ||
| P/B | 7.61 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.82 |
EPS(TTM)2.38
EY3.05%
EPS(NY)3.46
Fwd EY4.43%
FCF(TTM)3.32
FCFY4.25%
OCF(TTM)4.23
OCFY5.42%
SpS17.75
BVpS10.27
TBVpS-8.72
PEG (NY)0.72
PEG (5Y)N/A
Graham Number23.45
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| ROCE | 18.32% | ||
| ROIC | 12.65% | ||
| ROICexc | 12.94% | ||
| ROICexgc | 47.68% | ||
| OM | 27.52% | ||
| PM (TTM) | 13.04% | ||
| GM | 67.97% | ||
| FCFM | 18.72% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
ROICexc(3y)13.93%
ROICexc(5y)19.56%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.68%
ROCE(5y)29.74%
ROICexgc growth 3Y-12.46%
ROICexgc growth 5Y-4.64%
ROICexc growth 3Y-7.18%
ROICexc growth 5Y-21.95%
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 4.34 | ||
| Debt/EBITDA | 2.2 | ||
| Cap/Depr | 98.21% | ||
| Cap/Sales | 5.12% | ||
| Interest Coverage | 9.3 | ||
| Cash Conversion | 72.84% | ||
| Profit Quality | 143.51% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 3.99 |
F-Score6
WACC5.77%
ROIC/WACC2.19
Cap/Depr(3y)106.21%
Cap/Depr(5y)137.78%
Cap/Sales(3y)5.05%
Cap/Sales(5y)6.06%
Profit Quality(3y)77.98%
Profit Quality(5y)77.41%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.93%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%-20.03%
EPS Next Y45.69%
EPS Next 2Y27.02%
EPS Next 3Y23.6%
EPS Next 5Y17.18%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.1%
Revenue Next Year5.7%
Revenue Next 2Y6.56%
Revenue Next 3Y7.67%
Revenue Next 5Y7.53%
EBIT growth 1Y5.27%
EBIT growth 3Y3.54%
EBIT growth 5Y5.55%
EBIT Next Year28.29%
EBIT Next 3Y15.9%
EBIT Next 5Y12.37%
FCF growth 1Y268.5%
FCF growth 3Y9.61%
FCF growth 5Y6.39%
OCF growth 1Y140.59%
OCF growth 3Y9.24%
OCF growth 5Y6.9%
COLOPLAST-B / CBHD.DE FAQ
What is the ChartMill fundamental rating of COLOPLAST-B (CBHD.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CBHD.DE.
What is the valuation status for CBHD stock?
ChartMill assigns a valuation rating of 5 / 10 to COLOPLAST-B (CBHD.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for COLOPLAST-B?
COLOPLAST-B (CBHD.DE) has a profitability rating of 7 / 10.
Can you provide the financial health for CBHD stock?
The financial health rating of COLOPLAST-B (CBHD.DE) is 5 / 10.
What is the expected EPS growth for COLOPLAST-B (CBHD.DE) stock?
The Earnings per Share (EPS) of COLOPLAST-B (CBHD.DE) is expected to grow by 45.69% in the next year.